Genotyping of hepatitis C virus isolates by a new line probe assay using sequence information from both the 5′untranslated and the core regions

Journal of Virological Methods

Volumn 143, Issue 2, 2007, Pages 153-160

  Ross, R S ^a   Viazov, S ^a   Roggendorf, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

DNA immunoassay; Genotyping; Hepatitis C virus; Phylogenetic analyses; Reverse hybridisation test

Indexed keywords

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; BIOASSAY; CLINICAL LABORATORY; COMMERCIAL PHENOMENA; COMPARATIVE STUDY; FEMALE; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RNA EXTRACTION; SCHOOL CHILD; VIRUS CORE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS TYPING;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 34250704832     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.03.006     Document Type: Article

References (42)

1. Alter M.J., Hutin Y.J.F., and Armstrong G.L. Epidemiology of hepatitis C. In: Liang J.T., and Hoofnagle J. (Eds). Hepatitis C (2000), Academic Press, San Diego 169-183
2. Anonymous. National Institute of Health consensus development conference statement. Management of hepatitis C: 2002. Hepatology 36 (2002) S3-S15
3. Ansaldi F., Torre F., Bruzzone B.M., Picciotto A., Crovari P., and Icardi G. Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping. J. Med. Virol. 63 (2001) 17-21
4. Cantaloube J.-F., Laperche S., Gallina P., Bourchardeau F., de Lamballerie X., and de Micco P. Analysis of the 5′ noncoding region versus the NS5B region in genotyping hepatitis C virus isolates from blood donors in France. J. Clin. Microbiol. 44 (2006) 2051-2056
5. Chen Z., and Weck K.E. Hepatitis C virus genotyping: interrogation of the 5′untranslated region cannot accurately distinguish genotypes 1a and 1b. J. Clin. Microbiol. 40 (2002) 3127-3134
6. Chinchai T., Labout J., Noppornpanth S., Theamboonlers A., Haagmans B.L., Osterhaus A.D.M.E., and Poovorawan Y. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J. Virol. Methods 109 (2003) 195-201
7. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
8. Choo Q.-L., Richman K., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., and Houghton M. Genetic organization and diversity of hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2451-2455
9. De Francesco R., and Migliaccio G. Challenges and successes in developing new therapies for hepatitis C. Nature 436 (2005) 953-960
10. Felsenstein, J., 2006. PHYLIP (Phylogenetic Inference Package). Available at: http://evolution.gs.washington.edu/phylip.html (accessed November 15, 2006).
11. Garnier L., Inchauspé G., and Trépo C. Hepatitis C virus. In: Richman D.D., Whitley R.J., and Hayden F.G. (Eds). Clinical Virology. 2nd ed. (2002), ASM Press, Washington, DC 1153-1176
12. Halfon P., Trimoulet P., Bourliere M., Khiri H., de Ledighen V., Couzigou P., Feryn J.M., Alcaraz P., Renou C., Fleury H.J.A., and Ouzan D. Hepatitis C genotyping based on 5′ noncoding sequence analysis. J. Clin. Microbiol. 39 (2001) 1771-1773
13. Haushofer A.C., Berg J., Hauer R., Trubert-Exinger D., Stekel H.G., and Kessler H.H. Genotyping of hepatitis C virus. Comparison of three assays. J. Clin. Virol. 27 (2003) 276-285
14. Hnatyszyn H.J. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir. Ther. 10 (2005) 1-11
15. Kwok S., and Higuchi R. Avoiding false positives with PCR. Nature 339 (1989) 237-238
16. Lau J.Y., Davis G.L., Prescott L.E., Maertens G., Lindsay K.L., Qian K., Mizokami M., and Simmonds P. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann. Intern. Med. 124 (1996) 868-876
17. Lavanchy D., and McMahon B. Worldwide prevalence and prevention of hepatitis C. In: Liang J.T., and Hoofnagle J. (Eds). Hepatitis C (2000), Academic Press, San Diego 185-201
18. Lole K.S., Jha J.A., Shrotri S.P., Tandon B.N., Mohan Peasad V.G., and Arankalle V.A. Comparison of hepatitis C virus genotyping by 5′ noncoding region and core based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J. Clin. Microbiol. 41 (2003) 5240-5344
19. Müller Z., Deak J., Ross R.S., Nagy E., Kovacs L., Roggendorf M., and Kessler H.H. Hepatitis C virus genotypes in Hungarian and Austrian patients with chronic hepatitis C. J. Clin. Virol. 26 (2003) 295-300
20. Naoumov N.V., Chokshi S., Metivier E., Maertens G., Johnson P.J., and Williams R. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J. Hepatol. 27 (1997) 331-336
21. Nolte F.S. Hepatitis C virus genotyping: clinical implications and methods. Mol. Diag. 6 (2001) 265-277
22. Nolte F.S., Green A.M., Fiebelkorn K.R., Caliendo A.M., Sturchoi C., Grunwald A., and Healy M. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5′ noncoding region. J. Clin. Microbiol. 41 (2003) 1558-1564
23. Nousbaum J.B., Pol S., Nalpas B., Landais P., Berthelot P., and Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann. Intern. Med. 122 (1995) 161-168
24. Podzorski R.P. Molecular testing in the diagnosis and management of hepatitis C virus infection. Arch. Pathol. Lab. Med. 126 (2002) 285-290
25. Roque-Afonso A.M., Ferey M.-P., Povera J.-D., Marchadier E., and Dussaix E. Performance of TRUGENE hepatitis C virus 5′ noncoding genotyping kit, a new CLIP sequencing-based assay for hepatitis C virus genotype determination. J. Viral Hepatitis 9 (2002) 385-389
26. Ross R.S., Viazov S., Varenholz C., and Roggendorf M. Intraspousal transmission of hepatitis C virus: benefits and limitations of genome sequencing and phylogenetic analysis. Forensic Sci. Int. 100 (1999) 69-76
27. Ross R.S., Viazov S.O., Holtzer C.D., Beyou A., Monnet A., Mazure C., and Roggendorf M. Genotyping of hepatitis C virus isolates using CLIP sequencing. J. Clin. Microbiol. 38 (2000) 3581-3584
28. Ross R.S., Viazov S., Renzing-Köhler K., and Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J. Med. Virol. 60 (2000) 122-125
29. Sandres-Sauné K., Deny P., Pasquier C., Thibaut V., Duverlie G., and Izopet J. Determining hepatitis C virus genotype by analyzing the sequence of the NS5B region. J. Virol. Methods 109 (2003) 187-193
30. Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., Beall E., Yap P.L., Kolberg J., and Urdea M.S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74 (1993) 2391-2399
31. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., Halfon P., Inchauspe G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J.M., Penin F., Sablon E., Shin I.T., Stuyver L.J., Thiel H.J., Viazov S., Weiner A.J., and Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
32. Smith D.B., Mellor J., Jarvis L.M., Davidson F., Kolberg J., Urdea M., Yap P.L., and Simmonds P. Variation of the hepatitis C virus 5′ noncoding region: implications for secondary structure, virus detection and typing. J. Gen. Virol. 76 (1995) 1749-1761
33. Strimmer K., Haeseler A., and Salemi M. Nucleotide substitution models. In: Salemi M., and Vandamme A.-M. (Eds). The Phylogenetic Handbook. A Practical Approach to DNA and Protein Phylogeny (2003), Cambridge University Press, Cambridge 72-100
34. Stuyver L., Wyseur A., van Arnhem W., Hernandez F., and Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J. Clin. Microbiol. 34 (1996) 2259-2266
35. Tokita H., Okamoto H., Tsuda F., Song P., Nakata S., Chosa T., Iizuka H., Mishiro S., Miyakawa Y., and Mayumi M. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11022-11026
36. Viazov S., Zibert A., Ramakrishnan K., Widell A., Cavicchini A., Schreier E., and Roggendorf M. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J. Virol. Methods 48 (1994) 81-92
37. Viazov S., Kuzin S., Paladi N., Tchernovetsky M., Isaeva E., Mazhul L., Vasychova F., Widell A., and Roggendorf M. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Moldova, and Uzbekistan). J. Med. Virol. 53 (1997) 36-40
38. Viazov S., Widell A., and Nordenfeld E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 28 (2000) 21-25
39. Weck K. Molecular methods of hepatitis C genotyping. Expert Rev. Mol. Diag. 5 (2005) 507-520
40. Zein N.N., Poterucha J.J., Gross Jr. J.B., Wiesner R.H., Therneau T.M., Gossard A.A., Wendt N.K., Mitchell P.S., Germer J.J., and Persing D.H. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am. J. Gastroenterol. 91 (1996) 2560-2562
41. Zekri A.R.N., El-Din H.M.A., Bahnassy A.A., El-Shehabi A.M.R., El-Leethy H., Omar A., and Khaled H.M. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype 4. J. Med. Virol. 75 (2005) 412-420
42. Zheng X., Pang M., Chan A., Roberto A., Warner A., and Yen-Lieberman B. Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV 2.0 and TRUGENE HCV genotyping methods. J. Clin. Virol. 28 (2003) 214-216